44 results on '"Liu, Q."'
Search Results
2. PCN162 Disease Burden of Castration-Resistant Prostate Cancer (CRPC) in China
3. PCV76 COMTEMPORARY HEART FAILURE TREATMENT PATTERN AND COST IN CHINESE PATIENTS POPULATIONS
4. PMD8 COST-EFFECTIVENESS ANALYSIS OF TEGADERM CHLORHEXIDINE GLUCONATE(CHG) DRESSING VERSUS STANDARD DRESSING IN PATIENTS WITH CENTRAL VENOUS CATHETER IN CHINESE INTENSIVE CARE UNITS
5. AI1 AN INNOVATIVE ARTIFICIAL INTELLIGENCE APPLICATION IN DISEASE SCREENING: AN OPPORTUNITY TO IMPROVE MATERNAL HEALTH CARE IN AN UNDERDEVELOPED RURAL AREA
6. PCN286 COMPARING EQ-5D-3L AND EQ-5D-5L PSYCHOMETRIC PROPERTIES OF COMMON CANCERS IN CHINA: A CROSS-SECTIONAL STUDY
7. Health Related Quality of Life (Hrqol) and Cost Estimation For Patients With Knee Osteoarthritis Treated By Orthopedists-Supervised Physical Exercise Alone: A Perspective Cohort Study
8. Cost-Effectiveness of Elbasvir/Grazoprevir Versus Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir (3D Regimen) for Treatment of Chronic Hepatitis C Genotype 1B Patients in China
9. Epidemiological Characteristics, Medical Cost and Healthcare Resource Utilization of Diabetes-Related Complications Among Chinese Patients with Type 2 Diabetes Mellitus
10. Cost-Effectiveness of Orthopedists-Supervised Physical Exercise For Patients With Knee Osteoarthritis: A Study Protocol
11. The Cost-Effectiveness Analysis of Elbasvir/Grazoprevir Versus Peginterferon Αlpha-2A in Combination with Ribavirin in Patients with Chronic Hepatitis C Genotype 1b Infection in China
12. Off Label Use of Proton Pump Inhibitors and Economic Burden in Chinese Population: A Retrospective Analysis Using Claims Database
13. Health Resource Use and Cost Under Pay on Fee and Case-Based Payment in Hospitalized Patients with Chronic Obstructive Pulmonary Disease in China
14. Direct Medical Cost and Healthcare Resource Utilization in Elderly Patients with Type 2 Diabetes Mellitus Among Insured Urban Population in China
15. The Effectiveness of Pre-Filled Versus Manually Filled Flush Syringes in Intravascular Devices Maintenance: A Meta-Analysis
16. Administrative Claims Analysis of All-Cause Healthcare Resource Utilization for T2DM with Chronic Comorbidities Patients in China
17. PMS24 - Health Related Quality of Life (Hrqol) and Cost Estimation For Patients With Knee Osteoarthritis Treated By Orthopedists-Supervised Physical Exercise Alone: A Perspective Cohort Study
18. PMS18 - Cost-Effectiveness of Orthopedists-Supervised Physical Exercise For Patients With Knee Osteoarthritis: A Study Protocol
19. PIN19 - Cost-Effectiveness of Elbasvir/Grazoprevir Versus Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir (3D Regimen) for Treatment of Chronic Hepatitis C Genotype 1B Patients in China
20. PIN21 - The Cost-Effectiveness Analysis of Elbasvir/Grazoprevir Versus Peginterferon Αlpha-2A in Combination with Ribavirin in Patients with Chronic Hepatitis C Genotype 1b Infection in China
21. PDB38 - Epidemiological Characteristics, Medical Cost and Healthcare Resource Utilization of Diabetes-Related Complications Among Chinese Patients with Type 2 Diabetes Mellitus
22. Antidepressant Usage Patterns Of Patients With Major Depressive Disorder Initiated On Snris Compared With Ssris In Beijing, China
23. Antipsychotic Useage Patterns Of Patients With Schizophrenia In Beijing, China
24. Direct Cost and Medication Usage Among Insured Type 2 Diabetes Patients with Chronic Kidney Disease under Hospitalization in Beijing and Tianjin, China
25. Direct Medical Costs Associated with Multiple Myeloma in Chinese Patients: Estimations from China Public Health Insurance Claim Data
26. Characteristics and Healthcare Resource use of Patients with Major Depressive Disorder Initiated on Snri Compared to Ssri In Beijing China
27. Direct Medical Costs Associated With Ankylosing Spondylitis In Chinese Patients: Estimations From China Public Health Insurance Claim Data
28. Direct Cost and Medication Usage in Elderly Type 2 Diabetic Patients under Hospitalization among Insured Urban Population in China
29. PGI8 - Off Label Use of Proton Pump Inhibitors and Economic Burden in Chinese Population: A Retrospective Analysis Using Claims Database
30. Economic Analysis of Empiric Versus Diagnostic-Driven Strategies for Immunocompromised Patients With Suspected Aspergillus Invasive Fungal Infections In China
31. Medication use patterns, Health-care resource Utilization and Economic burden for patients with Schizophrenia in Beijing, China
32. PDB33 - Direct Medical Cost and Healthcare Resource Utilization in Elderly Patients with Type 2 Diabetes Mellitus Among Insured Urban Population in China
33. PMD25 - The Effectiveness of Pre-Filled Versus Manually Filled Flush Syringes in Intravascular Devices Maintenance: A Meta-Analysis
34. PRS15 - Health Resource Use and Cost Under Pay on Fee and Case-Based Payment in Hospitalized Patients with Chronic Obstructive Pulmonary Disease in China
35. PDB43 - Administrative Claims Analysis of All-Cause Healthcare Resource Utilization for T2DM with Chronic Comorbidities Patients in China
36. PMH44 - Antidepressant Usage Patterns Of Patients With Major Depressive Disorder Initiated On Snris Compared With Ssris In Beijing, China
37. PMH43 - Antipsychotic Useage Patterns Of Patients With Schizophrenia In Beijing, China
38. PCN103 - Direct Medical Costs Associated with Multiple Myeloma in Chinese Patients: Estimations from China Public Health Insurance Claim Data
39. PMH47 - Characteristics and Healthcare Resource use of Patients with Major Depressive Disorder Initiated on Snri Compared to Ssri In Beijing China
40. PDB47 - Direct Cost and Medication Usage Among Insured Type 2 Diabetes Patients with Chronic Kidney Disease under Hospitalization in Beijing and Tianjin, China
41. PDB46 - Direct Cost and Medication Usage in Elderly Type 2 Diabetic Patients under Hospitalization among Insured Urban Population in China
42. PIN55 - Economic Analysis of Empiric Versus Diagnostic-Driven Strategies for Immunocompromised Patients With Suspected Aspergillus Invasive Fungal Infections In China
43. PMH67 - Medication use patterns, Health-care resource Utilization and Economic burden for patients with Schizophrenia in Beijing, China
44. PSY39 - Direct Medical Costs Associated With Ankylosing Spondylitis In Chinese Patients: Estimations From China Public Health Insurance Claim Data
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.